Keyword Suggestion
Domain Informations
Minervaneurosciences.com lookup results from whois.register.com server:
- Domain created: 2013-10-29T23:24:55Z
- Domain updated: 2026-04-24T21:25:45Z
- Domain expires: 2026-10-29T23:24:55Z 0 Years, 71 Days left
- Website age: 12 Years, 293 Days
- Registrar Domain ID: 1833103734_DOMAIN_COM-VRSN
- Registrar Url: http://www.register.com
- Registrar WHOIS Server: whois.register.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS13.WORLDNIC.COM
- NS14.WORLDNIC.COM
Network
- inetnum : 104.207.128.0 - 104.207.129.255
- name : NET-104-207-128-0-23
- handle : NET-104-207-128-0-2
- status : Reassigned
- created : 2015-03-16
- changed : 2024-04-04
Owner
- organization : Vultr Holdings, LLC
- handle : VHL-78
- address : Array,Piscataway,NJ,08854,US
Abuse
- handle : VULTR-ARIN
- name : Vultr Abuse
- phone : +1-973-849-0500
- email : [email protected]
Technical support
- handle : VULTR-ARIN
- name : Vultr Abuse
- phone : +1-973-849-0500
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.207.129.84
- Location: Piscataway United States
- Latitude: 40.5511
- Longitude: -74.4606
- Timezone: America/New_York
Site Inspections
Port Scanner (IP: 104.207.129.84)
Spam Check (IP: 104.207.129.84)
Email address with minervaneurosciences.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
Recent Searched Sites
› Theartofsound.l-acoustics.com (3 seconds ago) / FR
› Fulcrumwa.planconfidence.com (21 seconds ago) / US
› Tullochwines.rezdy.com (0 seconds ago) / US
› Mashableposts.online (3 seconds ago) / US
› Mmaapf.org (4 seconds ago) / US
› Client.meshtastic.org (11 seconds ago) / US
› Voicescenter.org (16 seconds ago) / US
› Sietdeclaracion.rec.uba.ar (10 seconds ago) / AR
› Ir.aseglobal.com (4 seconds ago) / US
› Vivariumgame.com (2 seconds ago) / FR
› Cuaca.bmkg.go.id (4 seconds ago) / US
› Itu.edu (10 seconds ago) / US
› School.emis.ge (7 seconds ago) / GE
› Umeos.ru (31 seconds ago) / RU
› Test.datainmeta.com (6 seconds ago) / US
› Logon.shipcsx.com (12 seconds ago) / US
› Naplesdentalartcenterinc.com (9 seconds ago) / US
› Blackboardhotrods.com (2 seconds ago) / US
› Minervaneurosciences.com (0 seconds ago) / US
› Hanoverkoifarms.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with minervaneurosciences.com on Search Engine
Contact • Minerva Neurosciences
Minerva Neurosciences Inc. 1601 Trapelo Road, Suite 286 Waltham, MA 02451 617-600-7373 [email protected]. Investor or media inquiries: 617-600-7376
Minervaneurosciences.comMinerva Neurosciences
Our skills in clinical development define our core expertise in central nervous system disorders. We are focused on designing innovative trials with clinical endpoints directly related to patient benefit, and we seek to recruit patients who will benefit from treatment with our product candidates. Schizophrenia.
Minervaneurosciences.comMinerva Neurosciences, Inc. Email Format
Minerva Neurosciences, Inc. uses 2 email formats: 1. first_initial [email protected] (80.0%). Enter a name to find & verify an email >>> Enter a name to find & verify an email >>> Rocketreach finds email, phone & …
Rocketreach.coAbout Us • Minerva Neurosciences
Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed …
Minervaneurosciences.comPrivacy Policy • Minerva Neurosciences
Following our dispatch of an e-mail notice to you or thirty (30) calendar days following our posting of notice of the changes on our Site. These changes will be effective immediately for new users of our Site. Please note that at all times you are responsible for updating your personal information to provide us with your most current e-mail ...
Minervaneurosciences.comMINERVA NEUROSCIENCES Company Profile | Management and …
MINERVA NEUROSCIENCES Profile and History Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia; a potential royalty stream from seltorexant (MIN-202 or JNJ-42847922), in clinical development for insomnia and MDD; and MIN-301, in pre-clinical development for Parkinson's disease.
Datanyze.comMinerva Neurosciences, Inc. Information - RocketReach
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. Targeted disorders include schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and …
Rocketreach.coMINERVA NEUROSCIENCES - Overview, News & Competitors
Who is MINERVA NEUROSCIENCES. Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia; a potential royalty stream from seltorexant (MIN-2. 02 or JNJ-42847922), in clinical development for insomnia and MDD; and MIN-301, in pre-clinical development for Parkinson's disease.
Zoominfo.comMinerva Neurosciences Announces Study Results Demonstrating
2021-09-30 · CFO, Minerva Neurosciences Email. Media Inquiries: Helen Shik Principal, Shik Communications LLC Email. View source version on GlobeNewswire.com. Nasdaq:NERV. Minerva Neurosciences Inc. Latest NERV News. 05/04/22 8:30 AM Minerva Neurosciences Reports First Quarter 2022 Financial Results and Business Updates; 04/07/22 8:30 AM …
Stocktitan.netMinerva Neurosciences, Inc | VentureRadar
Minerva’s portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical... ... Find out more ...
Ventureradar.comJAMES HALEY, Vice CEO, audit, Minerva Neurosciences
Verify the professional email of JAMES HALEY, Vice CEO, audit, Minerva Neurosciences. Email-verifier.io : the best email verifier in the world. Email-verifier.io. Back to homepage Email-Verifier.io is the BEST email verifier in the world. Test us for free! First Name: James ...
Directory.email-verifier.ioMinerva Neurosciences, Inc. (NERV) Stock Price, News, Quote
Find the latest Minerva Neurosciences, Inc. (NERV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Finance.yahoo.comMinerva Neurosciences Inc - NERV Stock News | StockTitan.net
2022-03-01 · Minerva Neurosciences to Report Third Quarter 2021 Financial Results and Business Updates on November 8. Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release. RHEA-AI.
Stocktitan.netMinerva Neurosciences, Inc. (NERV) Company Profile & Facts
See the company profile for Minerva Neurosciences, Inc. (NERV) including business summary, industry/sector information, number of employees, business …
Finance.yahoo.comMinerva Neurosciences, Inc (NERV) Company Profile & Facts - Yahoo
See the company profile for Minerva Neurosciences, Inc (NERV) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation.
Ca.finance.yahoo.comNERV.O - Minerva Neurosciences Inc Profile | Reuters
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of product candidates to treat patients suffering from ...
Reuters.comMinerva Neurosciences Company Profile: Stock Performance
Minerva Neurosciences General Information Description. Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN ...
Pitchbook.comMinerva Neurosciences Inc - Company Profile and News
Company profile page for Minerva Neurosciences Inc including stock price, company news, press releases, executives, board members, and contact information
Bloomberg.comMinerva Neurosciences, Inc. (NERV) Exclusive Data & Insights
Get Minerva Neurosciences, Inc. (NERV) exclusive data and insights at your fingertips with intuitive visualizations.
Finance.yahoo.comMinerva Neurosciences Announces Study Results Demonstrating ...
2021-09-30 · Minerva Neurosciences, Inc. (Nasdaq: NERV) is a clinical-stage biopharmaceutical company focused on developing product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Minerva’s portfolio of compounds includes roluperidone (MIN-101), in clinical development for …
Ca.finance.yahoo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| jobzlk.com | godaddy.com | -3 Years, -334 Days |
| willsuttonlaw.com | wildwestdomains.com | -4 Years, -181 Days |
| zysanju.com | gname.com | -3 Years, -35 Days |
| inthefashionjungle.com | porkbun.com | -3 Years, -188 Days |
| ringke.com | gabia.com | -4 Years, -14 Days |
| tefujia.com | bizcn.com | -3 Years, -271 Days |
| sezonshd.org | publicdomainregistry.com | -4 Years, -155 Days |
| remini.pro | namecheap.com | -4 Years, -93 Days |
| businessrecord.com | networksolutions.com | -2 Years, -240 Days |
| zennitec.com | publicdomainregistry.com | -4 Years, -133 Days |